Cardiac Pacemaker Survey-Twenty Hospitals Pacemaker Implantation Registry in China
Chen Ruo-han,Chen Keping,Hua Wei,Xu Jing,Chen Lin,Su Yangang,Su Xi,Zou Jiangang,Yan Ji,Wang Jingfeng,Tang Baopeng,Xiang Meixiang,Zhang Shu
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2017.01.005
2017-01-01
Abstract:Objective To analyze the cardiac pacing therapy in China.Methods The analysis was based on the data from arrhythmic interventional therapy registry system which was part of unified database developed by the national center for cardiovascular disease.This analysis included 20 hospitals which were on the top of pacemaker implantation.Results A total of 5 467 patients[mean age:(69.1±12.7)years old,50.5％female(n=2 759)]were recruited between May 2013 and November 2015.Forty-four hundred and eleven(80.7％)patients were new-implanted,5 349(97.8％)patients underwent implantation due to bradycardia,4 493(82.2％)pacemakers were dual-chamber,3 938(72.1％)were rate adaptive pacemaker.Subclavian vein puncture was the most common approach for leads insertion.Axillary vein puncture was the second and exceeded cephalic vein cut-down.The right atrial appendage(92.26％)and right ventricular apex(54.10％)were still the common site for leads implantation,but the percentage of right ventricular septum increased to 45.31％.Conclusion This registry study shows that the pacing therapy is improved in recently years in China.The physiological pacing(dual-chamber and ventricular septum pacing)is employed in more patients.